The identification of the specific signaling pathway activated by CXCR2 provides a novel regulatory mechanism of STAT3 activation in myeloid cell differentiation and a potential strategy for reducing immune suppression in the tumor microenvironment. Here, STAT3 is linked to neoplasm.